The following is a listing of recent U.S. Food and Drug Administration updates and activities:

• FDA alerts patients and health care professionals about clinical trial results showing an increased risk of death associated with Pepaxto (melphalan flufenamide)

• Rabies: Developing Monoclonal Antibody Cocktails for the Passive Immunization Component of Post-Exposure Prophylaxis Guidance for Industry

…

Sign Up for Free Trial

---

• Back
• MCN Blog